Involvement of Caveolin-1 in CD83 Internalization in Mouse Dendritic Cells
To become potent T-cell stimulators, DCs need to mature. Treatment with soluble CD83 (sCD83) induces immune tolerance and protects against transplant rejection by maintaining dendritic cells in an immature, tolerogenic state. Until now, the mechanism through which sCD83 keeps DCs immature has not be...
Main Authors: | Yuejing Yang, Zhongcheng Xin, Jingjia Chu, Na Li, Tao Sun M.D., Ph.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-07-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368914X682116 |
Similar Items
-
Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody
by: Ziduo Li, et al.
Published: (2020-01-01) -
Caveolin-1 involvement in prostate cancer
by: Day, Elizabeth Helen
Published: (2011) -
Soluble CD83 Alleviates Experimental Autoimmune Uveitis by Inhibiting Filamentous Actin-Dependent Calcium Release in Dendritic Cells
by: Wei Lin, et al.
Published: (2018-07-01) -
Caveolin-1 Expression Increases upon Maturation in Dendritic Cells and Promotes Their Migration to Lymph Nodes Thereby Favoring the Induction of CD8+ T Cell Responses
by: Cesar Oyarce, et al.
Published: (2017-12-01) -
The CD83 Molecule – An Important Immune Checkpoint
by: Linda Grosche, et al.
Published: (2020-04-01)